Stefano Lancellotti, PhD

Biologist Health Manager
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Center for Hemorrhagic and Thrombotic Diseases and Haemophilia Center, Rome, Italy
Roma, Lazio, Italy

Lancellotti Stefano (phD), “Osteoclast role in Haemophilic Bone disease”. Haemostasis and Thrombosis Center of Foundation “A. Gemelli” Hospital IRCCS of Rome, Italy. He has been working for over 10 years in the field of hemostasis and thrombosis. He earned a PhD in Pathophysiology and Pharmacology of Hemostasis and Thrombosis (2007-2010 Catholic University of Sacred Heart in Rome ) and a specialization in Clinical Biochemistry (2006-2007 and 2010-2013 Catholic University of Sacred Heart in Rome)
Since 2021, he is the Lazio regional contact person for the Italian Society for the Study of Haemostasis and Thrombosis (SISET).

Presentation(s):

• PB0170 - Evaluation of the Extended-Half Life FVIII products' measurement accuracy and precision with five different types of laboratory assays.

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0811 - Natural variants of von Willebrand factor R1205 associated with type 1 von Willebrand disease: in-silico docking models and energetics of the interactions with the macrophagic scavenger receptor LRP1.

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB0820 - In silico evidence of the conformational transitions associated with the p.R854Q mutation in the D’D3 domain of von Willebrand factor, responsible for its weakened FVIII interaction.

  Monday, June 26, 2023
  18:30 – 19:30 ET